TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,384,650 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch […]
Drug Patent Expirations for the Week of March 14, 2021 Read Post »
Annual Drug Patent Expirations for BIKTARVY Biktarvy is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug BIKTARVY Read Post »
Annual Drug Patent Expirations for SYMTUZA Symtuza is a drug marketed by Janssen Prods and is included in one NDA.
New patent expiration for Janssen Prods drug SYMTUZA Read Post »
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one
New patent expiration for Abbvie Inc drug ORIAHNN (COPACKAGED) Read Post »
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie Inc and is included in one NDA.
New patent expiration for Abbvie Inc drug ORILISSA Read Post »
Annual Drug Patent Expirations for NUPLAZID Nuplazid is a drug marketed by Acadia Pharms Inc and is included in two
New patent expiration for Acadia Pharms drug NUPLAZID Read Post »
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA.
New patent expiration for Evofem Inc drug PHEXXI Read Post »
ANDROGEL (testosterone) Abbvie Patent: 6,503,894 Expiration: Mar 2, 2021 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of February 28, 2021 Read Post »
Get fresh news and insights, drug patent expirations & more…
